GE HEALTHCARE TECHNOLOGIES INC. Net Income (Loss) Attributable to Noncontrolling Interest
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Net Income (Loss) Attributable to Noncontrolling Interest of $22.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $22.00M, a 8.33% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $13.00M, a 23.53% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $18.00M, a 5.26% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was $14.00M, a 100.00% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $70.00M, a 22.81% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $57.00M, a 23.91% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $46.00M, a 9.80% decline from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $51.00M, a 10.87% increase from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $22.00M 10-Q · filed 2026-04-29 | $35.00M derived: sum of 2 quarters · filed 2026-04-29 | $53.00M derived: sum of 3 quarters · filed 2026-04-29 | $67.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $31.00M derived: sum of 2 quarters · filed 2026-02-04 | $45.00M derived: sum of 3 quarters · filed 2026-02-04 | $70.00M 10-K · filed 2026-02-04 |
| 2025-09-30 | $18.00M 10-Q · filed 2025-10-29 | $32.00M derived: sum of 2 quarters · filed 2025-10-29 | $57.00M 10-Q · filed 2025-10-29 | $73.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $14.00M 10-Q · filed 2025-07-30 | $39.00M 10-Q · filed 2025-07-30 | $55.00M derived: sum of 3 quarters · filed 2026-04-29 | $74.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $24.00M 10-Q · filed 2026-04-29 | $41.00M derived: sum of 2 quarters · filed 2026-04-29 | $60.00M derived: sum of 3 quarters · filed 2026-04-29 | $67.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $36.00M derived: sum of 2 quarters · filed 2026-02-04 | $43.00M derived: sum of 3 quarters · filed 2026-02-04 | $57.00M 10-K · filed 2026-02-04 |
| 2024-09-30 | $19.00M 10-Q · filed 2025-10-29 | $26.00M derived: sum of 2 quarters · filed 2025-10-29 | $40.00M 10-Q · filed 2025-10-29 | $53.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $7.00M 10-Q · filed 2025-07-30 | $21.00M 10-Q · filed 2025-07-30 | $34.00M derived: sum of 3 quarters · filed 2026-02-04 | $41.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $14.00M 10-Q · filed 2025-04-30 | $27.00M derived: sum of 2 quarters · filed 2026-02-04 | $34.00M derived: sum of 3 quarters · filed 2026-02-04 | $49.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $20.00M derived: sum of 2 quarters · filed 2026-02-04 | $35.00M derived: sum of 3 quarters · filed 2026-02-04 | $46.00M 10-K · filed 2026-02-04 |
| 2023-09-30 | $7.00M 10-Q · filed 2024-10-30 | $22.00M derived: sum of 2 quarters · filed 2024-10-30 | $33.00M 10-Q · filed 2024-10-30 | $52.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $15.00M 10-Q · filed 2024-07-31 | $26.00M 10-Q · filed 2024-07-31 | $45.00M derived: sum of 3 quarters · filed 2025-02-13 | $51.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $11.00M 10-Q · filed 2024-04-30 | $30.00M derived: sum of 2 quarters · filed 2025-02-13 | $36.00M derived: sum of 3 quarters · filed 2025-02-13 | $49.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $25.00M derived: sum of 2 quarters · filed 2025-02-13 | $38.00M derived: sum of 3 quarters · filed 2025-02-13 | $51.00M 10-K · filed 2025-02-13 |
| 2022-09-30 | $6.00M 10-Q · filed 2023-10-31 | $19.00M derived: sum of 2 quarters · filed 2023-10-31 | $32.00M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $13.00M 10-Q · filed 2023-07-25 | $26.00M 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $13.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $46.00M 10-K · filed 2024-02-06 |